Replies to post #65438 on SOHM Inc (SHMN)

[drugmanrx]

Nothing currently to get excited about.

SOHM Inc. Signed an Exclusive Distribution Agreement with India-based Stallion Laboratories Pvt. Ltd. for Levetiracetam for the Treatment of Epilepsy

https://finance.yahoo.com/news/sohm-inc-signed-exclusive-distribution-133000543.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAE5tDcjcW193_sa7Ke3ZA06XcyT-GWBNxGO_oomTSA_PqnAVPXcOo5_MyXdmZp4lenWJQst9iR__AB1gd6V1pb-g6Lg42-8w5OvW7ON7wnehc1dZiVtEhyAr7xKvcPpe3dl7HenGEomiFu2zAMv7cAhlm-CfkuwzDZywQ8zZdxOW

Based on 2023 revenues ($19,025 4st quarter 2023, $402,645 for the year 2023) SOHM Inc distribution territory is currently not that vast.